🔎 Trials Near Me

Home › Neuroblastoma › Minnesota › Minneapolis

Neuroblastoma clinical trials in Minneapolis, MN

8 studies for Neuroblastoma are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RecruitingPhase 3
  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

RecruitingPhase 2
  • Children's Hospital and Clinics of Minnesota, Minneapolis
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RecruitingPhase 3
  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • University of Minnesota/Masonic Cancer Center, Minneapolis
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

RecruitingPhase 2
  • Children's Hospital and Clinics of Minnesota, Minneapolis
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2
  • Children's Hospital and Clinics of Minn, Minneapolis
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

RecruitingPhase 2
  • Masonic Cancer Center, University of Minnesota, Minneapolis
Up to age 30 · All sexes · Updated Oct 21, 2025 · NCT02605421

International PPB/DICER1 Registry

RecruitingObservational studyHealthy volunteers welcome
  • Children's Minnesota, Minneapolis
0 Minutes – 100 Years · All sexes · Updated Jan 30, 2025 · NCT03382158

About Neuroblastoma

Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.

More about Neuroblastoma on MedlinePlus

Neuroblastoma trials in other cities

Other studies in Minneapolis

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.